Plasmid platform protype
Ended Other Transaction Agreement Awarded Last action
- Contract number
- W911QY1990009
- Awardee
-
Resilience Government Services, Inc. UEI GC2RFAZK8G64
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Obligated
- $3,880,954
Award facts
- Contract value 76% obligated
-
- $3,880,954.31 Current, with exercised options
- $5,107,357.36 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Competed Broad Agency Announcement
- Pricing
- Other
- Place of performance
- Santa Fe, FL 32615, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$359,243 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $800,000 | |
| Supplemental Agreement for work within scope | $1,000,000 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $313,556 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $2,126,641 |
About this award
The Department of Defense, through the Joint Program Executive Office (PEO) for Chemical and Biological Defense, awarded an Other Transaction Agreement valued at approximately $5.1 million to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.) on March 22, 2019, for development of a plasmid platform prototype. The contract, which was completed by December 31, 2020, carried no small business set-aside designation. Performance of work occurred in Alachua, Florida. As a biomanufacturing company specializing in complex pharmaceutical manufacturing and medical countermeasures, Resilience was selected to advance prototype development capabilities in support of the Department of Defense's chemical and biological defense mission.
This award represents part of Resilience Government Services' broader engagement with the Department of Defense on medical countermeasure initiatives. The company currently maintains two active Indefinite Delivery Vehicles with the Army's Acquisition Support Center, including a $5.7 million Other Transaction IDIQ focused on demonstrating medical countermeasure capabilities and a $249 million single-award Indefinite Delivery Contract for acquisition of FDA-approved products supporting chemical and biological defense programs. Resilience's work across these vehicles has encompassed process development, clinical trials, regulatory support, and manufacturing scale-up activities aimed at achieving FDA licensure for medical countermeasures addressing biological threats.
Quick answers
Who was awarded contract W911QY1990009?
W911QY1990009 was awarded to Resilience Government Services, Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on March 22, 2019.
How much is contract W911QY1990009 worth?
The government has obligated $3,880,954 on W911QY1990009. Its potential value, with all options, is $5,107,357.
Which agency awarded contract W911QY1990009?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY1990009, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W911QY1990009 competed?
The extent of competition for W911QY1990009 was competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award